Table 3.
Outcome measure | Pre-intervention M (SD) [range] | Analysis protocol | Post-intervention M (SD) | Follow-up M (SD) | Effect size, Cohen's d [95% confidence intervals for T0–T1] | Linear mixed model, Type III test of fixed effects (using all available data) | T0–T1 pairwise comparison: mean difference (SE), significant* |
T0–T2 pairwise comparison: mean difference (SE), significant* |
T1–T2 pairwise comparison: mean difference (SE), significant* |
---|---|---|---|---|---|---|---|---|---|
TFI | 58.4 (15.01) [24–90] |
Completers analysis | 29.98 (20.99) [2–86] |
29.53 (21.55) [3–84] | 1.60 [0.91, 2.23] | F(2, 43) = 34.42, p = .001* | 28.04 (SE = 3.94), p = .001 * | 29.48 (SE = 4.30), p = .001 * | 1.44 (SE = 4.46), p = 1.00 |
Imputation analysis | 29.55 (19.36) [2–86] | 29.71 (17.49) | 1.76 [1.11, 2.36] | ||||||
GAD-7 | 7.15 (4.68) [1–17] | Completers analysis | 4.57 (4.02) [0–14] | 4.35 (2.42) [0–9] | 0.58 [−0.02, 1.16] | F(2, 39) = 7.07, p = .002* | 2.74 (SE = 0.82), p = .005 * | 2.68 (SE = 0.91), p = .01* | −.07 (SE = 0.93), p = 1.00 |
Imputation analysis | 4.69 (3.75) [0–14] | 4.91 (2.43) [0–9] | 0.58 [0.03, 1.12] | ||||||
PHQ-9 | 6.00 (3.17) [0–12] | Completers analysis | 4.91 (3.94) [0–14] | 4.71 (2.78) [1–9] | 0.30 [−0.28, 0.89] | F(2, 39) = 1.99, p = .15 | N/A N/A |
||
Imputation analysis | 4.76 (3.71) [0–14] | 4.52 (2.51) [1–9] | 0.36 [−0.18, 0.89] | ||||||
ISI | 12.67 (6.50) [2–27] | Completers analysis | 8.85 (6.02) [0–20] 7.04 (4.81) |
11.53 (6.43) [1–23] | 0.61 [0.01, 1.19] | F(2, 35) = 7.90, p = .001* | 4.32 (SE = 1.09), p = .001* | 2.43 (SE = 1.16), p = .13 | −1.90 (SE = 1.20), p = .37 |
Imputation analysis | 8.74 (5.35) [0–20] | 10.69 (5.27) [1–23] | 0.66 [0.10, 1.20] | ||||||
EQ-5D-5L | 7.33 (1.94) [5–15] | Completers analysis | 6.40 (1.19) [5–9] | 6.53 (1.18) [5–9] | 0.56 [−0.04, 1.14] | F(2, 32) = 6.73, p = .004* | 0.90 (SE = 0.26), p = .005* | .77 (SE = 0.28), p = .03 * | −.13 (SE = 0.30), p = 1.00 |
Imputation analysis | 6.57 (1.15) [5–9] | 6.42 (1.01) [5–9] | 0.46 [−0.13, 1.04] | ||||||
EQ-5D-5L VAS | 73.85 (16.03) [9–90] |
Completers analysis | 81.60 (7.50) [70–90] | 80.94 (10.35) [50–90] | 0.59 [−0.01, 1.17] | F(2, 18) = 2.63, p = .10 | N/A | ||
Imputation analysis | 80.71 (6.96) [70–90] | 81.01 (8.42) [50–90 | 0.56 [0.00, 1.09] | ||||||
THS: Tinnitus | 7.15 (4.13) [1–6] | Completers analysis | 3.70 (4.47) [0–14] | 3.69 (4.27) [0–16] | 0.81 [0.19, 1.39] | F(2, 36) = 15.17, p = .001* | 3.31 (SE = 0.68), p = .001* | 3.28 (SE = 0.74), p = .001* | −.03 (SE = 0.77), p = 1.0 |
Imputation analysis | 3.87 (3.91) [0–14] | 3.61 (3.54) [0–16] | 0.82 [0.25, 1.36] | ||||||
THS: Hearing | 7.04 (4.33) [0–16] | Completers analysis | 4.05 (3.65) [0–12] | 3.69 (3.30) [0–12] | 0.74 [0.13, 1.32] | F(2, 36) = 10.39, p = .001* | 2.9 (SE = 0.76), p = .002* | 3.2 (SE = 0.82), p = .001* | .36 (SE = 0.85), p = 1.0 |
Imputation analysis | 4.32 (3.2) [0–12] | 3.41 (2.86) [0–12] | 0.71 [0.15, 1.25] | ||||||
THS: Sound tolerance | 1.33 (1.24) [0–4] | Completers analysis | 0.60 (0.82) [0–3] | 0.81 (0.98) [0–3] | 0.67 [0.07, 1.26] | F(2, 36) = 7.23, p = .002* | 0.76 (SE = 0.21), p = .002* | .48 (SE = 0.23), p = .11 | −.29 (SE = 0.23), p = .66 |
Imputation analysis | 0.61 (0.76) [0–3] | 0.84 (0.89) [0–3] | 0.70 [0.14, 1.24] | ||||||
TCQ | 41.7 (11.37) [22–62] | Completers analysis | 29.65 (13.94) [11–57] | 29.19 (13.11) [7–48] | 1.76 [1.06, 2.41] | F(2, 37) = 13.87, p = .001* | 12.00 (SE = 2.63), p = .001 * | 12.27 (SE = 2.86), p = .001* | −.27 (SE = 2.97), p = 1.0 |
Imputation analysis | 29.47 (12.02) [11–57] | 30.01 (10.37) [7–48) | 1.05 [0.46, 1.60] |
Note. Results from both the completers and imputation analysis are provided for comparison. TFI = Tinnitus Functional Index; GAD-7 = Generalized Anxiety Disorder-7; PHQ-9 = Patient Health Questionnarie-9; ISI = Insomnia Severity Index; EQ-5D = EuroQol measure; VAS = Visual Analogue Scale; THS = Tinnitus Hearing Screener; TCQ = Tinnitus Cognitions Questionnaire; N/A = not applicable.
Significance at p < .05.